A team led by researchers at Baylor College of Medicine and Washington University School of Medicine has shed light on the process that drives Barrett’s esophagus formation. This condition affects the lining of the esophagus – the tube that carries food …

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a known precursor to esophageal cancer, according to a new study from researchers at the University of Cambridge, Addenbrooke…

Raised lesions of dysplastic Barrett's esophagus (BE) are treated with endoscopic mucosal resection (EMR) before ablation. But the procedure causes bleeding in 10% of cases. Reporting at the American College of Gastroenterology Annual Scientific …

(MENAFN- PR Newswire) BALTIMORE, Feb. 12, 2025 /PRNewswire/ -- Today, Previse, a gastrointestinal health company, announced a newly published study in the American Journal of Gastroenterology, which provides additional clinical validation of …

FOR IMMEDIATE RELEASE By studying biomarkers known to be involved in gastrointestinal cancers, researchers at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a biomarker algorithm that, when …

This year, more than 22,000 Americans face a chilling diagnosis: esophageal cancer. Men are three to four times more likely to develop it, and there is a less than 20% chance of surviving five years. But what if an early diagnosis could change that? A new …

Epigenetic test for risk-stratification impacts gastroenterologists' decision making and improves confidence when caring for patients with Barrett's esophagus. BALTIMORE, Oct. 28, 2024 /PRNewswire/ -- Previse, a gastrointestinal health …

Funder: Dr. Aoki is supported by theAPAGE/JGH Foundation Clinician-ScientistTraining Fellowship. Dr. Bulamu is supported bya Cancer Council South Australia Beat CancerEarly Career Research Fellowship From: Flinders University New research is exploring …

TOPLINE: A new epigenetic assay is able to stratify patients with Barrett's esophagus into lower-risk and higher-risk categories for progression to high-grade dysplasia or esophageal adenocarcinoma within 5 years, aiding in clinical decision-making. …

A new, non-invasive test called ESOGuard is giving patients a better chance at surviving one of the deadliest cancers in the country. More than 22,0000 Americans are expected to be diagnosed with esophageal cancer. The disease disproportionately affects …